Upcoming Webinar
Tech Talks: MedTech Investment Trends—Navigating the Future with Data-Driven Insights
From diagnostics and digital health to robotics and remote care, the medtech sector is evolving rapidly—but so is the funding environment. Join PitchBook’s Sr. Healthcare Analyst Aaron DeGagne as he convenes a panel of medtech market leaders to break down what’s driving funding momentum, where the biggest opportunities lie, and how startups can navigate a shifting market landscape. Whether you’re building, investing, or analyzing in medtech, this webinar offers actionable takeaways on the state of the market—and explores what’s next for this innovative and important sector.
To download the presentation slides and watch the recording, please fill out the form.
Key Takeaways
- Global medtech investment trends and emerging areas of opportunity
- Investor expectations vs. startup realities: what makes a startup fundable
- Navigating today’s market environment: key challenges, bright spots, and what to watch
Featuring
-
Aaron DeGagne
-
Dr. Dylan Attard is a surgical doctor by background who operates at the intersection of MedTech, venture capital, events, and media. As the leader of MedTech World, he is dedicated to fostering innovation and entrepreneurship in healthcare. In addition to his work with MedTech World, he is a Venture Partner at Ikigai Ventures, where he helps drive investment in groundbreaking technologies. Now, he is embarking on a new venture with Ubunto Ventures, further expanding his commitment to advancing the MedTech ecosystem and supporting transformative healthcare solutions.
-
Ken Nelson is a Partner at MedTech Advantage Fund with two decades of experience in digital health, medical devices, and remote monitoring. He has played a key role in the commercial success of some of the industry’s most disruptive technologies. Over the past 10 years, Ken has led go-to-market efforts in wearables and cardiac remote patient monitoring, helping build the teams and cultures behind three of the top four market share leaders: BioTelemetry (#1), iRhythm (#2), and Bardy Diagnostics (#4). His track record includes multiple successful exits, including BioTelemetry’s $2.8B acquisition by Philips and Bardy Diagnostics’ $400M+ acquisition by HillRom.
Ken also serves as a strategic advisor and judge for MedTech Innovator, the industry’s nonprofit global competition and accelerator for medical device, digital health, and diagnostic companies. Through this work, he supports the organization’s mission to improve patient lives by accelerating the growth of healthcare innovators.
-
Paul Grand is the founder and CEO of MedTech Innovator, the largest and most impactful accelerator of medical technology in the world.
MedTech Innovator’s rigorous review process identifies and accelerates the most promising early-stage companies in the world. With a 5% acceptance rate, MedTech Innovator’s 717 graduates have collectively brought over 400 products to market, raised $9.5B in follow-on funding post-graduation, and improved millions of lives.
Prior to MedTech Innovator, Paul was a serial entrepreneur starting companies in the biopharma, medtech, and tech industries. He became a venture capitalist in 2005, when he joined RCT Ventures, an early-stage life science investor where he served as Managing Director. At RCT, Paul focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013 and left to run MedTech Innovator as a stand-alone company with RCT’s support in 2016. Paul became a member of the RCT Board of Directors in 2023.
